Tandem Diabetes Care Stock News

Tandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday, continuing a decline that has already cost the company two-thirds of its market value this year.

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -800% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the

Tandem Diabetes Care, Krispy Kreme, Caesars Entertainment and Vestas Wind Systems are part of Zacks Screen of the week article.

RxSight, Inc. (RXST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Detoxify your portfolio by selling stocks like Tandem Diabetes (TNDM) Krispy Kreme (DNUT), Caesars Entertainment (CZR) and Vestas Wind (VWDRY).

Detoxify your portfolio by selling stocks like Tandem Diabetes (TNDM) Krispy Kreme (DNUT), Caesars Entertainment (CZR) and Vestas Wind (VWDRY).

Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Upgrades According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur

Just like identifying promising stocks, detecting toxic stocks and dumping them at the right time are crucial to safeguarding one's portfolio from big losses.

Just like identifying promising stocks, detecting toxic stocks and dumping them at the right time are crucial to safeguarding one's portfolio from big losses.

Upgrades For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte

All three stocks are worth keeping a lot longer than half a decade.

Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 1 0

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the f

InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group have been highlighted in this Screen of The Week article.